Melissa Horhey

Doctor of Medicine,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Pharma-CRO-Device Grant Submission Biostatistics Career Advice and Mentoring Data Science-Bioinformatics

Areas Of Interest

Deer Mouse Pelvic Bones Transcriptase, Telomerase Reverse Sombrevin Fluids, Intercellular B-Cell Leukemia 2 Family Proteins Biosynthetic Pathways Ureaplasma parvum Real-Time System Neotrombicula Genitourinary Systems Urban Renewals Guam Form of Amyotrophic Lateral Sclerosis Orthomyxovirus Type A, Avian Pharmaceuticals, Veterinary Sulfachloropyridazine CPSF-100-kDa Subunit Mutation Rate Perch Injury, Cranial Nerve IV Cress, Rock Concept Testing Proofs National Institute of Biomedical Imaging and Bioengineering (U.S.) Encystation, Parasite Vaccine, Diphtheria-Pertussis-Tetanus

Professional Narrative

Dr. Melissa Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Harvard Med 2014
Assistant Professor, Amgen 2001

Education

Doctor of medicine, Perelman School of Medicine 1992
Director Medicine, Yale School of Medicine 1996

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :